Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Kidswell Bio
AddedFeb 13, 2024
UpdatedJun 28, 2026
Kidswell Bio

Kidswell Bio

Acquired

Gene Techno Science: A Japan-based R&D firm specializing in biopharmaceuticals and oncology treatments.

HQ
Tokyo, Tokyo, JP
Founded
2001
Overview
Compare
Fundraising
Employees

Kidswell Bio, originally founded as Gene Techno Science in 2001 and headquartered in Sapporo, Japan, is dedicated to the research and development of biopharmaceutical products and biosimilars. The company's core mission is to advance healthcare through innovative treatments for immunological, cardiovascular, ophthalmic, infectious, and renal diseases, alongside oncology. Kidswell Bio offers a range of products, including Filgrastim for cancer treatment, focusing on improving patient outcomes in Japan and potentially globally.

Notable figures associated with Kidswell Bio include its founders and key researchers who have driven its scientific advancements. The company has attracted significant investment from both private and public sectors, reflecting confidence in its innovative potential. Key achievements include the successful development and commercialization of several biopharmaceutical products, contributing to improved healthcare solutions. Kidswell Bio's impact is marked by its commitment to addressing critical medical needs through cutting-edge research and development.

Kidswell Bio - Similar Companies

Oncolys BioPharma logo

Oncolys BioPharma

oncolys.com

Kyowa Kirin Co. logo

Kyowa Kirin Co.

kyowakirin.com

Katana Pharmaceuticals logo

Katana Pharmaceuticals

SK Bioscience logo

SK Bioscience

skbioscience.co.kr

BioRay Pharmaceuticals logo

BioRay Pharmaceuticals

BioPro Pharmaceutical logo

BioPro Pharmaceutical

JK BioPharma Solutions logo

JK BioPharma Solutions

Essex Bio-Technology logo

Essex Bio-Technology

Walden Biosciences logo

Walden Biosciences

Taiho Pharmaceutical Co. logo

Taiho Pharmaceutical Co.

taiho.co.jp

Superior Biologics logo

Superior Biologics

Brii Biosciences logo

Brii Biosciences

briibio.com

Apic Bio logo

Apic Bio

BridGene Biosciences logo

BridGene Biosciences

Biocon logo

Biocon

biocon.com

Kidswell Bio - Quick Facts

Who are Kidswell Bio's competitors?

Companies similar to Kidswell Bio include Oncolys BioPharma, Kyowa Kirin Co., Katana Pharmaceuticals and SK Bioscience.

When was Kidswell Bio founded?

Kidswell Bio was founded in 2001.

Where is Kidswell Bio's headquarters located?

Kidswell Bio's headquarters is located in Tokyo, Tokyo, JP.

When was Kidswell Bio's last funding round?

Kidswell Bio's most recent funding round was for $1.2B (USD) in February 2013.

How much has Kidswell Bio raised to-date?

As of Feb 28, 2013, Kidswell Bio has raised a total of $2.7B (USD).

Kidswell Bio - Classification

NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified